MehdiMirsaeidiMDMPH

Pulmonology • Jacksonville, FL

Critical Care Medicine, Infectious Disease, Interstitial Lung Diseases, Pleural Disease

Professor, Division of Pulmonary and Critical Care

Join to view full profile

Dr. Mirsaeidi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mirsaeidi's full profile

Already have an account?

Office
West 8th Street
Division of Pulmonary and Critical Care, University of Florida
Jacksonville, FL 32209
Phone+1 904-244-0411

Summary

Dr. Mehdi Mirsaeidi is a pulmonologist in Jacksonville, FL and is affiliated with multiple hospitals in the area, including University of Florida Hospital and UF-North and Clinics. He received his medical degree from Other and has been in practice 24 years. He also speaks multiple languages, including Farsi. He specializes in critical care medicine, infectious disease, and interstitial lung diseases and is experienced in interstitial lung disease, sarcoidosis, and mycobacterial infections.

Education & Training

University of Illinois College of Medicine at ChicagoFellowship, Pulmonary Disease and Critical Care Medicine, 2011 - 2015
Providence HospitalResidency, Internal Medicine, 2008 - 2011
University of Louisville School of MedicinePost-Doctoral Fellowship, 2007 - 2009
University of TehranMPH, 1998 - 1999
OtherClass of 1993

Certifications & Licensure

FL State Medical License 2015 - 2025
IL State Medical License 2011 - 2017
DC State Medical License 2008 - 2011
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Critical Care Medicine

Awards, Honors, & Recognition

Scholarship Award American Thoracic Society, 2014
Abstract Scholarship Assembly on Microbiology, Tuberculosis & Pulmonary Infections (MTPI)/ American Thoracic Society, 2014
Best Scientific Poster American College of Physician, 2009-2010
Research Development Award Veterans Health Administration, 2008
Best Scientific Poster Award American College of Physicians, 2008-2009
Award as a Judge of the Poster Competition Executive Vice President for Health Affairs, 2007
Treatment & Medical Education Scientific Award Iranian Ministry of Health, 2004
Award for Academic Contributions Pakistani Chest Society, 2004
Award for Scientific Contributions in Medical Counseling Iranian State Organization of Welfare Cultural & Prevention Affairs Deputy, 2002
Join now to see all

Clinical Trials

Treatment Outcomes in Patient With Nontuberculous Mycobacterial Disease Start of enrollment: 2012 Sep 01
Terminated
Study to Evaluate the Safety and Efficacy of ATYR1923 (Efzofitimod) In Participants With Severe Pneumonia Related to COVID-19 Start of enrollment: 2020 Jun 04
Completed
Phase 2

Publications & Presentations

PubMed

1579 citations
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Qian Zhang, Paul Bastard, Zhiyong Liu, Jérémie Le Pen, Marcela Moncada-Vélez
Science. 2020-10-23
3 citations
COVID-19 Prediction using Genomic Footprint of SARS-CoV-2 in Air, Surface Swab and Wastewater Samples.
Helena M Solo-Gabriele, Shelja Kumar, Samantha Abelson, Johnathon Penso, Julio Contreras
Medrxiv. 2022-04-01
38 citations
SARS-CoV-2 cell entry beyond the ACE2 receptor.
Shamila D Alipoor, Mehdi Mirsaeidi
Molecular Biology Reports. 2022-11-01

Journal Articles

Recurrent Drug-Induced Hepatitis in Tuberculosis-Comparison of Two Drug Regimens
Shamaei M, Mirsaeidi M, Baghaei P, Mosaei H, Marjani M, Tabarsi P, Am J Ther, 1/1/2017
Toll-like receptors in mycobacterial infection
Vu A, Calzadilla A, Gidfar S, Calderon-Candelario R, Mirsaeidi M, Eur J Pharmacol, 1/1/2017
Bovis Bacillus Calmette-Guerin (BCG) infection induces exosomal miRNA release by human macrophages
Alipoor SD, Mortaz E, Tabarsi P, et al, J Transl Med, 1/1/2017
Mycobacterium aquaticum sp nov, a rapidly growing species isolated from haemodialysis water
ashemi Shahraki A, Trovato A, Droz S, et al, nt J Syst Evol Microbiol, 1/1/2017
Improving adherence to alpha-1 antitrypsin deficiency screening guidelines using the pulmonary function laboratory
Luna Diaz LV, Iupe I, Zavala B, et al, Int J Chron Obstruct Pulmon Dis, 1/1/2017
A risky political game with climate change
Mirsaeidi M, Javadzadeh A, Campos M, Eur Respir J, 1/1/2017
A Patient-Based Analysis of the Geographic Distribution of Mycobacterium avium complex, Mycobacterium abscessus, and Mycobacterium kansasii Infections in the United St...
Mirsaeidi M, Vu A, Leitman P, et al, Chest, 1/1/2017
Cardiovascular complications and mortality determinants in near drowning victims: A 5-year retrospective analysis
Omar HR, Mirsaeidi M, Bosco G, et al, J Crit Care, 1/1/2017
Noncoding RNAs, New Players in Pulmonary Medicine and Sarcoidosis
Salamo O, Mortaz E, Mirsaeidi M, Am J Respir Cell Mol Biol, 1/1/2017
Body habitus in patients with and without bronchiectasis and non-tuberculous mycobacteria
Schweitzer MD, Salamo O, Campos M, Schraufnagel DE, Sadikot R, Mirsaeidi M, PLoS One, 1/1/2017
Sarcoidosis onset after breast cancer; a potential association
Schweitzer MD, Salamo O, Holt G, Donna E, Mirsaeidi M, Eur J Intern Med, 1/1/2017
Mycobacterium persicum sp nov, a novel species closely related to Mycobacterium kansasii and Mycobacterium gastri
Shahraki AH, Trovato A, Mirsaeidi M, et al, Int J Syst Evol Microbiol, 1/1/2017
Annexins family: insights into their functions and potential role in pathogenesis of sarcoidosis
Mirsaeidi M, Gidfar S, Vu A, Schraufnagel D, J Transl Med, 1/1/2016
Management of extrapulmonary sarcoidosis: challenges and solutions
Al-Kofahi K, Korsten P, Ascoli C, et al, Ther Clin Risk Manag, 1/1/2016
The roles of miRNAs as potential biomarkers in lung diseases
Alipoor SD, Adcock IM, Garssen J, et al, Eur J Pharmacol, 1/1/2016
Exosomes and Exosomal miRNA in Respiratory Diseases
Alipoor SD, Mortaz E, Garssen J, Movassaghi M, Mirsaeidi M, Adcock IM, Mediators Inflamm, 1/1/2016
High prevalence of Mycobacterium tuberculosis mixed infection in the capital of moderate tuberculosis incidence country
Hajimiri ES, Masoomi M, Ebrahimzadeh N, et al, Microb Pathog, 1/1/2016
Microbiological Analysis of Hemodialysis Water in a Developing Country
Heidarieh P, Hashemi Shahraki A, Yaghoubfar R, Hajehasani A, Mirsaeidi M, ASAIO J, 1/1/2016
In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran
Heidarieh P, Mirsaeidi M, Hashemzadeh M, et al, Microb Drug Resist, 1/1/2016
Haarlem 3 is the predominant genotype family in multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in the capital of Iran: A 5-year survey
Khanipour S, Ebrahimzadeh N, Masoumi M, et al, J Glob Antimicrob Resist, 1/1/2016
Plasma metabolomic profile in fibrosing pulmonary sarcoidosis
Mirsaeidi M, Banoei MM, Nienow CK, et al, Sarcoidosis Vasc Diffuse Lung Dis, 1/1/2016
Reply: Metabolomics and Mycobacterial Disease: Don't Forget the Bioinformatics
Mirsaeidi M, Banoei MM, Winston BW, Schraufnagel DE, Ann Am Thorac Soc, 1/1/2016
Association of Neutrophil to Lymphocyte Ratio and Pulmonary Hypertension in Sarcoidosis Patients
Mirsaeidi M, Mortaz E, Omar HR, Camporesi EM, Sweiss N, Tanaffos, 1/1/2016
The Association between ESR and CRP and Systemic Hypertension in Sarcoidosis
Mirsaeidi M, Omar HR, Ebrahimi G, Campos M, Int J Hypertens, 1/1/2016
Annexin A11 is associated with pulmonary fibrosis in African American patients with sarcoidosis
Mirsaeidi M, Vu A, Zhang W, et al, Sarcoidosis Vasc Diffuse Lung Dis, 1/1/2016
Join now to see all

Books/Book Chapters

Severe Acute Respiratory Syndrome (SARS)
Mirsaeidi SM, Amiri MNRITLD (National Research Institute of Tuberculosis and Lung Diseases)2004
Textbook of Pediatric Respiratory Diseases
Chapter: Respiratory infections in children with HIV infection.
Mirsaeidi SMShaheed Beheshti University of Medical Sciences2004

Abstracts/Posters

Geographic Diversity of Non-Tuberculous Mycobacteria Species Among NTM Patients in the USA.
M Mirsaeidi, P. Leitman, M. Campos, M. Salathe, American Thoracic Society, San Francisco, CA, 1/1/2016
Gender Differences in Alpha-1-Antitrypsin Deficiency.
MA Pardinas Gutierrez, M Mirsaeidi, RA Sandhaus, M. Campos, American Thoracic Society, San Francisco, CA, 1/1/2016
A descriptive analysis of nontuberculous mycobacterial infections (NTM) of the upper extremity.
M Al-Knawy, W Bosch, H Garner, M Mirsaeidi, J Cawley, P Murray, Asian African Society of Mycobacteriology, Isfehan, Iran, 1/1/2015
Missed Opportunities To Prevent Active Tb In Undocumented Latino Immigrants.
M Mirsaeidi, S Hashmi, K Haas, DE Schraufnagel, American Thoracic Society, San Diego, CA, 1/1/2014
Nontuberculous Mycobacterial Disease Mortality In The United States, 1999-2010: A Population-Based Comparative Study.
M Mirsaeidi, RF Machado, JGN Garcia, DE Schraufnagel, American Thoracic Society, San Diego, CA, 1/1/2014
Patient-Centered Tuberculosis Treatment With Using Video-Direct Observed Therapy.
M Mirsaeidi, S Hashmi, DE Schraufnagel, American Thoracic Society, San Diego, CA, 1/1/2014
Nontuberculous Mycobacterial Disease Is Common In Patients With Non-Cystic Fibrosis Bronchiectasis.
M. Mirsaeidi, W. Hadid, B. Ericsoussi, D. Rodgers, R.T. Sadikot, American Thoracic Society, Philadelphia, PA, 1/1/2013
Early Antibiotic Administration Does Not Decrease Mortality in Hospitalized Patients with Community-Acquired-Pneumonia: Results from the CAPO International Cohort Study.
S. Smith, D Newman, M. Mirsaeidi, P. Peyrani, T. Wiemken, J. Ramirez and the CAPO Investigators, 47th Annual IDSA Meeting, Philadelphia, PA, 1/1/2009
Pleural Effusion Predicts Poor Outcomes in Hospitalized Patients with Community-Acquired Pneumonia: Results from the CAPO International Cohort Study.
R Nakamatsu, M. Mirsaeidi, P. Peyrani, F. Arnolad, J. Ramirez, and the CAPO Investigator, 47th Annual IDSA Meeting, Philadelphia, PA, 1/1/2009
Influence of Age in the Mortality of Elderly and Very Elderly Patients Hospitalized with Community-Acquired Pneumonia: Results from the CAPO International Cohort Study.
R. Nakamatsu, M. Mirsaeidi, P. Peyrani, F. Arnold, M. Allen, J. Ramiez, and the CAPO Investigators, 47th Annual IDSA Meeting, Philadelphia, PA, 1/1/2009
Imaging Studies To Define the Need for Aspiration of Para-Pneumonic Effusions in Hospitalized Patients with Community-Acquired Pneumonia.
R. Nakamatsu, B. Moffett, E. Ayaya, M. Mirsaeidi, F. Arnold, P. Peyrani, J. Ramiez, 47th Annual IDSA Meeting, Philadelphia, PA, 1/1/2009
Evaluation of the Management of Para-Pneumonic Effusions in Hospitalized Patients with Community-Acquired Pneumonia.
F. Arnold, R.Nakamatsu, M. Mirsaeidi, E. Anaya, B. Moffett, P. Peyrani, J. Ramirez, 47th Annual IDSA Meeting, Philadelphia, PA, 1/1/2009
Penicillin-resistant streptococcus pneumoniae is a rare etiology of community-acquired pneumonia requiring hospitalization: results from the CAPO international cohort ...
Mehdi Mirsaeidi MD, Paula Peyrani MD, Alejandro Diaz Fuenzalida MD, Jose Gonzalez MD, Lucia Marzoratti MD, Ivan Toala MD, Ludwig Rivero MD, Julio Ramirez MD and the CA..., European Respiratory Society, Berlin, Germany, 1/1/2008
Acute myocardial infarction in hospitalized patients with community-acquired pneumonia: results from the CAPO international cohort study.
Julio Ramirez,MD, Stefano Aliberti, MD, Mehdi Mirsaeidi, MD, Paula Peyrani, MD Giovanni Filardo, PhD,Gur Levy,MD, Patricia Fernandez, MD, Delfino Legnani, MD, Marilyn ..., European Respiratory Society, Berlin, Germany, 1/1/2008
Thrombocytosis predicts poor outcomes in patients with community-acquired pneumonia: results from the CAPO international cohort study.
Mehdi Mirsaeidi MD, Paula Peyrani MD, Stefano Aliberti MD, Giovanni Filardo PhD, Francesco Blasi MD, Harmut Lode MD, Juan Manuel Luna MD, Maria Teresa Parada, MD, Juli..., European Respiratory Society, Berlin, Germany, 1/1/2008
Female gender is associated with poor clinical outcomes in hospitalized patients with community-acquired pneumonia: results from the CAPO international cohort study.
Mehdi Mirsaeidi MD, Paula Peyrani MD, Jessica Portillo MD, Marty Allen MD, Federico Arteta MD, Jose Porras MD, Jorge Roig MD, Eduardo Rodriguez, MD, Maria Rodriguez, M..., European Respiratory Society, Berlin, Germany, 1/1/2008
Pleural effusion predicts poor outcomes in hospitalized patients with community-acquired pneumonia: results from the CAPO international cohort study.
Mehdi Mirsaeidi MD, Jessica Portillo MD, Ervin Anaya MD, Paula Peyrani MD, Juan Guardiola MD, Forest Arnold MD, Raul Nakamatsu MD, Carlos Victorio MD, Gonzalo AielloMD..., European Respiratory Society, Berlin, Germany, 1/1/2008
Predicting Mortality in Patients with Ventilator-Associated Pneumonia: The APACHE II score versus the new IBMP-10 score. Results from the IMPACT-HAP Study.
Mehdi Mirsaeidi MD, Paula Peyrani MD, Julio Ramirez MD, 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, 1/1/2008
Making the Microbiological Diagnosis in Patients with Healthcare-Associated Pneumonia, Hospital-Acquired Pneumonia, and Ventilator-Associated Pneumonia: Role of Bacter...
Mehdi Mirsaeidi MD, Paula Peyrani MD, Julio Ramirez MD, 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, 1/1/2008
Variability of Hospital Cost for Patients with Ventilator-Associated Pneumonia: Results from the IMPACT-HAP Study.
P. Peyrani, T. Wiemken, M. Mirsaeidi, M. Gnoni, J. Ramirez, and The Impact-hap Study Group, 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, 1/1/2008
Emergence of Community-Associated Methicillin Resistant Staphylococcus aurous as Etiology of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: Results f...
M. Allen, M. ALLEN, M. Mirsaeidi, P. Peyrani, J. Mangio, M. Zervo, D. Kett. K. Ford, E. Scerpella, J. Ramirez, and The Impact-hap Study Group, 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, 1/1/2008
The study of TH1 and TH2 cytokines profile (FN gamma,IL-12, IL-4, IL-10) in PBMCs of patients with MDR-TB and newly diagnose treated cases tuberculosis.
Miandehi, N., Shekarabi, M, Mansoori, D, Kheiri, M. T, Mirsaeedi, M, Infection Genetics and Evolution, 1/1/2008
Representative drug susceptibility patterns for guiding design of retreatment regimens for MDR-TB in IRAN.
Tabarsi P, Mirsaeidi M, Yadegarinia D, Masjedi MR, 45th Annual Meeting of Infectious Diseases Society of America, San Diego, CA, 1/1/2007
Representative drug susceptibility patterns for guiding design of retreatment regimens for MDR - TB in Iran.
P. Tabarsi, A. Nooraki, P. Baghaei, M. Mirsaeidi, M. Amiri, D. Mansouri, M. R. Masjedi, 17th Annual Congress of the European Respiratory Society, Stockholm, Sweden, 1/1/2007
Comparison of the efficacy of two methods of treatment, standard and modified, on patients with Isoniazid resistant tuberculosis.
P. Tabarsi, P. Baghaei, M. Mirsaeidi, M. Amiri, M. R. Masjedi, 17th Annual Congress of the European Respiratory Society, Stockholm, Sweden, 1/1/2007
Join now to see all

Other

"Community Acquired Pneumonia and Myocardial Infarctions; New Concepts, New Approach"
Mirsaeidi SM, Arab Health Magazine
Dubai, United Arab Emirates - 1/1/2008
Lung cancer epidemiology.
Mirsaeidi SM, Weekly Periodical of Pezeshki Emrooz (Iranian Medical Magazine)
Botulism.
Mirsaeidi SM, Weekly Periodical of Pezeshki Emrooz (Iranian Medical Magazine)
Cholera: A horrifying disease and Typhoid (Enteric) fever.
Mirsaeidi SM, Weekly Periodical of Pezeshki Emrooz (Iranian Medical Magazine)
Join now to see all

Press Mentions

Miller School Researchers Say the Indian Variant Is the Most ConcerningJune 22nd, 2021
University of Miami Health System Sarcoidosis Program Named Center of ExcellenceNovember 5th, 2020
University of Miami Health System Sarcoidosis Program Recognized as Center of ExcellenceNovember 4th, 2020
Join now to see all